Systematic review of systemic therapy for advanced or recurrent endometrial cancer
- 1 April 2006
- journal article
- review article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 101 (1), 158-167
- https://doi.org/10.1016/j.ygyno.2005.11.019
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Current treatment options for endometrial cancerExpert Review of Anticancer Therapy, 2004
- Phase III randomized trial of doxorubicin + cisplatin versus doxorubicin + 24-h paclitaxel + filgrastim in endometrial carcinoma: a Gynecologic Oncology Group studyAnnals Of Oncology, 2004
- Phase III Trial of Doxorubicin Plus Cisplatin With or Without Paclitaxel Plus Filgrastim in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2004
- Randomized Phase III Trial of Standard Timed Doxorubicin Plus Cisplatin Versus Circadian Timed Doxorubicin Plus Cisplatin in Stage III and IV or Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2003
- Megestrol and Tamoxifen in Patients With Advanced Endometrial CancerAmerican Journal of Clinical Oncology, 2001
- Novel strategies for systemic treatment of endometrial cancerExpert Opinion on Investigational Drugs, 2000
- Paclitaxel and Cisplatin in Advanced or Recurrent Carcinoma of the Endometrium: Long-Term Results of a Phase II Multicenter StudyGynecologic Oncology, 2000
- Efficacy of sequential cyclical hormonal therapy in endometrial cancer and its correlation with steroid hormone receptor statusGynecologic Oncology, 1988
- Randomized phase II studies of cisplatin and a combination of cyclophosphamide-doxorubicin-cisplatin (CAP) in patients with progestin-refractory advanced endometrial carcinomaGynecologic Oncology, 1987
- Tamoxifen and medroxyprogesterone therapy for advanced endometrial carcinomaEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1984